Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Comparisons between Haploidentical Hematopoietic Stem Cell Transplantation and Eltrombopag Adding to Standard Immunosuppression in Patients with Severe Aplastic Anemia

Andie Fu, Mengyuan Li, Yizhou Peng, Bin Xu, Li Li, Jin-song Jia, Yan Yang, Shengyun Lin, Jia Wei, Fankai Meng, Donghua Zhang, Guangsheng He

Blood (2024) 144 (Supplement 1): 3567.

https://doi.org/10.1182/blood-2024-199689

Published: 2024

Journal Articles

The Expression of BTG1 in De Novo AML Patients Regulated By Demethylation of Decitabine and Its Evaluation in the Deep Remission of Patients

Shiyuan Zhang, Mengyuan Li, Xiaojian Zhu, Hao Zhou, Bin Xu, Xiwen Tong, Su Shuai, Yi Zhu, Yi Xiao, Liang Huang, Dengju Li, Wei Huang, Jia Wei, Mei Huang, Donghua Zhang

Blood (2024) 144 (Supplement 1): 1401.

https://doi.org/10.1182/blood-2024-205864

Published: 2024

Journal Articles

Efficacy of Decitabine in Combination with IA Versus IA in Patients with Newly Diagnosed AML, a Multicenter, Prospective, Randomized Controlled Trial

Xiwen Tong, Bin Xu, Shiyuan Zhang, Xiaojian Zhu, Mengyuan Li, Su Shuai, Yi Zhu, Zhenqian Huang, Yaya Wang, Yi Xiao, Liang Huang, Dengju Li, Wei Huang, Jia Wei, Mei Huang, Zhiping Huang, Yuanyan Tang, Hongbo Ren, Donghua Zhang

Blood (2024) 144 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2024-205769

Published: 2024

Journal Articles

Selinexor in Combination with Standard or Reduced-Dose Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma

Su Shuai, Bin Xu, Chunrui Li, Di Wang, Xiwen Tong, Yi Zhu, Xia Mao, Min Xiao, Donghua Zhang

Blood (2024) 144 (Supplement 1): 7062.

https://doi.org/10.1182/blood-2024-204278

Published: 2024

Journal Articles

Prognostic and Therapeutic Implications of Early Assessment in AML and MDS Patients Treated with Selinexor-Containing Chemotherapy-Free Regimen

Su Shuai, Bin Xu, Xiwen Tong, Yi Zhu, Shiyuan Zhang, Xia Mao, Zhiqiong Wang, Min Xiao, Donghua Zhang, Jia Wei

Blood (2024) 144 (Supplement 1): 6004.

https://doi.org/10.1182/blood-2024-205664

Published: 2024

Journal Articles

Selinexor-Based Chemotherapy-Free or Low-Dose Chemotherapy Regimens in Acute Myeloid Leukemia, Myelodysplastic Syndromes: Efficacy and Safety

Xiwen Tong, Bin Xu, Su Shuai, Yi Zhu, Jin Jie, Yizhou Peng, Li Li, Mengyuan Li, Xia Mao, Wei Huang, Donghua Zhang, Jia Wei

Blood (2024) 144 (Supplement 1): 6003.

https://doi.org/10.1182/blood-2024-205493

Published: 2024

Journal Articles

Impact of Selinexor on AML Cell Lines and Healthy Donor T Cell Function: Enhanced Treg Cell Proportion

Xiwen Tong, Xiaojian Zhu, Su Shuai, Yi Zhu, Bin Xu, Yizhou Peng, Shiyuan Zhang, Jin Jie, Xia Mao, Jia Wei, Donghua Zhang

Blood (2024) 144 (Supplement 1): 5817.

https://doi.org/10.1182/blood-2024-205174

Published: 2024

Journal Articles

Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study

Weijun Fu, Juan Du, Lu Zhong, Lijuan Chen, Jian Li, Donghua Zhang, Jianqing Mi, Yan Liu, Sheng Wu, Richard Labotka, Cong Li, Wenhan Jiang, Wenming Chen

Blood (2023) 142 (Supplement 1): 6735.

https://doi.org/10.1182/blood-2023-181444

Published: 2023

Journal Articles

Real-World Experience with Selinexor -Containing Regimens in Post-Transplant AML/MDS Patients Who MRD Still Positive after First-Line Preemptive Treatment

Xiwen Tong, Shuai Su, Bin Xu, Xiaojian Zhu, Yizhou Peng, Jin Jie, Xia Mao, Min Xiao, Jay Mei, Donghua Zhang

Blood (2023) 142 (Supplement 1): 5837.

https://doi.org/10.1182/blood-2023-186006

Published: 2023

Journal Articles

Ksd-101 in Patients with EBV-Associated Hematologic Neoplasms: Results from an Ongoing Phase I Clinical Study

Chunrui Li, Di Wang, Atsuhiko Hasegawa, Huining Liu, Ning An, Yuhan Bao, Meijuan Huang, Yi Xiao, Donghua Zhang, Miao Zheng, Wei Huang, Lijun Jiang

Blood (2023) 142 (Supplement 1): 4837.

https://doi.org/10.1182/blood-2023-182556

Published: 2023

Journal Articles

Prolonged Use of Eltrombopag in Patients with Severe Aplastic Anemia without Complete Response at 6 Months after Immunosuppressive Therapy

Ruixin Li, Qiqiang Long, Yan Yang, Shengyun Lin, Jinsong Jia, Donghua Zhang, Guangsheng He, Jianyong Li

Blood (2022) 140 (Supplement 1): 8650–8651.

https://doi.org/10.1182/blood-2022-165120

Published: 2022

Journal Articles

Co-Transplantation of Mesenchymal Stem Cells Can Ameliorates Acute Gvhd and Viremia after Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multi-Center Retrospective Study of 119 Patients

Minmin Chen, Zhizhong Zheng, Guangsheng He, Prof.Dr., Shengyun Lin, Prof.Dr., Donghua Zhang, Prof.Dr., Huijing Hu, Jia Liu, Zhizhe Chen, Prof.Dr., Jianda Hu, Prof.Dr., Ting Yang

Blood (2018) 132 (Supplement 1): 4653.

https://doi.org/10.1182/blood-2018-99-118758

Published: 2018

Journal Articles

Monitoring CML28 mRNA Levels in Patients before and Post HSCT by Real-Time Quantitative RT-PCR.

Donghua Zhang, Min Dai, Hongsheng Zhou, Yaya Wang, Lu Zhang, Li Zhang, Bin Wang, Wenjing Cao

Blood (2005) 106 (11): 4478.

https://doi.org/10.1182/blood.V106.11.4478.4478

Published: 2005

Journal Articles

Induction of CML28-Specific Cytotoxic T Cells by Dendritic Cells Cotransfected with CML28 Nucleic Acid Vaccination and SOCS1-Specific siRNA Expression Vector In Vitro.

Donghua Zhang, Hongsheng Zhou, Lu Zhang, Yaya Wang, Min Dai, Li Zhang

Blood (2005) 106 (11): 3058.

https://doi.org/10.1182/blood.V106.11.3058.3058

Published: 2005

Journal Articles

The Construction of HA-1-DC Nucleic-Acid Vaccine and Induction of Specific Cytotoxic T Lymphocytes.

Donghua Zhang, Yaya Wang, Hongsheng Zhou, Zhenqian Huang, Huo Tan

Blood (2005) 106 (11): 5523.

https://doi.org/10.1182/blood.V106.11.5523.5523

Published: 2005

Journal Articles

Dendritic Cells Tranfected with CML-28 cDNA Induce CML28-Specific Cytotoxic T Cells.

Hongsheng Zhou, Donghua Zhang, Yaya Wang, Yi Xiao, Wei Huang, Dengju Li

Blood (2004) 104 (11): 5248.

https://doi.org/10.1182/blood.V104.11.5248.5248

Published: 2004

NARROW

Comparisons between Haploidentical Hematopoietic Stem Cell Transplantation and Eltrombopag Adding to Standard Immunosuppression in Patients with Severe Aplastic Anemia

The Expression of BTG1 in De Novo AML Patients Regulated By Demethylation of Decitabine and Its Evaluation in the Deep Remission of Patients

Efficacy of Decitabine in Combination with IA Versus IA in Patients with Newly Diagnosed AML, a Multicenter, Prospective, Randomized Controlled Trial

Selinexor in Combination with Standard or Reduced-Dose Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma

Prognostic and Therapeutic Implications of Early Assessment in AML and MDS Patients Treated with Selinexor-Containing Chemotherapy-Free Regimen

Selinexor-Based Chemotherapy-Free or Low-Dose Chemotherapy Regimens in Acute Myeloid Leukemia, Myelodysplastic Syndromes: Efficacy and Safety

Impact of Selinexor on AML Cell Lines and Healthy Donor T Cell Function: Enhanced Treg Cell Proportion

Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study

Real-World Experience with Selinexor -Containing Regimens in Post-Transplant AML/MDS Patients Who MRD Still Positive after First-Line Preemptive Treatment

Ksd-101 in Patients with EBV-Associated Hematologic Neoplasms: Results from an Ongoing Phase I Clinical Study

Prolonged Use of Eltrombopag in Patients with Severe Aplastic Anemia without Complete Response at 6 Months after Immunosuppressive Therapy

Co-Transplantation of Mesenchymal Stem Cells Can Ameliorates Acute Gvhd and Viremia after Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multi-Center Retrospective Study of 119 Patients

Monitoring CML28 mRNA Levels in Patients before and Post HSCT by Real-Time Quantitative RT-PCR.

Induction of CML28-Specific Cytotoxic T Cells by Dendritic Cells Cotransfected with CML28 Nucleic Acid Vaccination and SOCS1-Specific siRNA Expression Vector In Vitro.

The Construction of HA-1-DC Nucleic-Acid Vaccine and Induction of Specific Cytotoxic T Lymphocytes.

Dendritic Cells Tranfected with CML-28 cDNA Induce CML28-Specific Cytotoxic T Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only